Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Oral Octreolin™ in Patients With Acromegaly Who Are Currently Receiving Parenteral Somatostatin Analogs

NCT01412424 is registered in ClinicalTrials.gov with Chiasma, Inc. as lead sponsor.

NCT NCT01412424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01412424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Oral Octreolin™ in Patients With Acromegaly Who Are Currently Receiving Parenteral Somatostatin Analogs
Lead sponsor
Chiasma, Inc.
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2012
Completion date
May 31, 2014
Enrollment
155 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

acromegaly